A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis

NCT07343778 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B With Hepatic Fibrosis

Interventions

DRUG: Hydronidone Capsules

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.